INTRAUTERINE TRANSFUSION
I T was not until 1963 that Liley in New Zealand first described a technique of intrauterine transfusion whereby Rh negative donor cells were injected into the foetal peritoneal cavity early in pregnancy and were absorbed into the foetal circulation. Since then workers in many centres throughout the world have attempted, with varying degrees of success, to employ this technique, or one of its modifications. On page 277 of this issue of the Scottish Medical Journal a further modification, as used by the group of workers at Carluke, is described in a preliminary report. In the 15 patients subjected to intrauterine transfusion, 9 are reported to have achieved surviving infants though no details of the selection of cases, or the maturity at first transfusion is given. This survival rate (60 %) is much higher than that generally reported in the world literature (where the survival in 291 cases reported up to January 1967 was 41 %).
By judicious employment of exchange transfusion and selection of cases for treatment based on the levels of haemoglobin and bilirubin in the cord blood at birth, a steady decline in the neonatal death rate due to Rh haemolytic disease has been achieved over the past 15 years. This has not been matched by any similar decline in the stillbirth rate and therefore our main efforts are now directed towards preventing stillbirth. Until such time as immunisation may be prevented, antibodies neutralised, or their passage through the placenta prevented, premature induction remains the treatment of choice, but because of the danger of prematurity it must be restricted to patients where stillbirth is almost inevitable, and delayed as late in pregnancy as is compatible with livebirth. Even given a perfect method of selecting patients for induction so that the optimal time for interference could be determined, it would provide only a partial solution to the problem because 50 per cent of stillbirths SCOTTISH MEDICAL JOURNAL GLASGOW AUGUST 1967 occur before 35 weeks and 30 per cent even before 32 weeks gestation. Intrauterine transfusion has been advocated not to replace the need for premature induction but as a method of prolonging intrauterine life in those cases where intrauterine death early in pregnancy is anticipated until such time as premature induction can be safely undertaken (generally around 35-36 weeks). At the present time, 3 methods of prediction of cases of Rh iso-immunisation at risk from stillbirth are commonly employed:
(1) previous obstetric history-in relation to Rh affected infants; (2) maternal serum antibody titre; and (3) liquor examination for the presence of bilirubin.
Various centres have their own criteria for the performance and interpretation of (2) and (3). Generally, however, by a combination of information so obtained the case for premature induction can be identified. When employed, premature induction used to be undertaken as early as 32 weeks gestation in patients where more than one previous pregnancy had resulted in stillbirth due to haemolytic disease of the new-born, but at 34 to 35 weeks in the others. The danger of severe haemolytic disease of the newborn especially when combined with prematurity is shown by the experience of Walker et al. (1966) where over 40 per cent of infants induced at 32 weeks gestation died, as did about 20 per cent induced at 35 weeks. It was for such cases that Liley introduced the technique of intrauterine transfusion. It may in time be shown to have a place not only in preventing very early intrauterine death but also in preventing those which occur about 32 weeks, by enabling induction to be delayed until about 35 weeks. It follows, of course, that the selection of cases for intrauterine transfusion is critical.
Before embarking on intrauterine transfusion the placental site must be identified either as described by Black et al. (p. 277) or preferably by percutaneous femoral arteriography or the use of radio-isotope scan before the first amniocentesis. The various modifications of technique of transfusion such as described in this issue, now basically involve the use in the X-ray department of image intensifier, television screen and video-tape for control of insertion of the Tuohy needle into the foetal peritoneal cavity. Some workers inject radio-opaque dye into the liquor some hours before the intrauterine transfusion so that foetal bowel outlines are visible (the foetus having swallowed the dye), to assist in localisation of the target area, but other workers find this unnecessary and only check the position of the needle after insertion by identifying the foetal diaphragmatic shadow ro the typical crescent pattern outlining loops of foetal bowel following injection of a small quantity of radio-opaque dye either down the needle or down the catheter.
The choice of radio-opaque dye has not yet been considered critical but Hughes (1967) has shown that dyes such as Conray, or Myodil give rise to spontaneous agglutination, false ABO grouping and haemolysis when mixed with donor cells. Hypaque appears to be the most satisfactory dye but even with this the use of minimal quantities is advised. The volume of blood transfused should be related to the stage of gestationvarying from about 30 ml. at 24 weeks to 120 ml. at about 32 weeks.
There is no doubt that this procedure is potentially dangerous and there are reports of accidental puncture of sites other than the foetal peritoneal cavity-e.g. pleural cavity, bladder, pericardium, bowel, and it is reasonable to assume that not a few infants may have been killed by the procedure (Walker et al., 1966) . A further hazard, of course, is that incorrect selection may result in unnecessary transfusion of an Rh negative infant (Fairweather, 1967) . Recent reports from this country (Karnicki & Holman, 1966; Gordon et al., 1966) draw attention to a considerable risk of causing premature labour by intrauterine transfusion-as high as 65 per cent in one series.
It is also clear that the time of first intrauterine transfusion is directly related to the success rate in terms of foetal survival. In Karnicki's series (1966) there were only 3 survivors out of 19 infants transfused before 30 weeks, whilst there were 24 survivors out of 35 infants transfused for the first time after this gestation. This pattern is borne out in other series, and one is bound to suspect in some of the reports that certain of the cases would have done equally well had they not been subjected to intrauterine transfusion.
How then should we view intrauterine transfusion today? It seems clear that some cases certainly benefit from this form of treatment. However, it is a potentially dangerous technique both to mother and foetus and requires a skilled team of workers -obstetrician, radiologist, haematologist, paediatrician-and specialised facilities not readily available in all centres. This procedure should certainly be carried out only in a few selected centres where these facilities and staff are available. The cases should be critically selected and carefully followed up so that a proper evaluation of the indications for and the success of the procedure can be made, to guide us in the future. THE UNUSUAL CASE For some time it has been editorial policy to keep the number of papers based on reports of single unusual cases to an absolute minimum. We believe that this has increased the worth of the Scottish Medical Journal and we hope that readers have welcomed the policy. But it is a fact of medicine that the unusual case is extremely interesting to the majority of doctors engaged in clinical work and indeed is on occasion of considerable value in that it may give an insight into some of the unsolved clinical problems that are seen in our hospitals. For these reasons the Editorial Committee has decided to publish from time to time unusual cases, in short case report form, under the heading of Medical Memoranda and the first of such reports appears in this issue.
